152 related articles for article (PubMed ID: 33488258)
21. Docking-based 3D-QSAR and pharmacophore studies on diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Liu G; Wan Y; Wang W; Fang S; Gu S; Ju X
Mol Divers; 2019 Feb; 23(1):107-121. PubMed ID: 30051344
[TBL] [Abstract][Full Text] [Related]
22. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of novel 3,5-disubstituted-1,2,6-thiadiazine-1,1-dione derivatives as HIV-1 NNRTIs.
Tian Y; Rai D; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu H; Liu X
Chem Biol Drug Des; 2013 Oct; 82(4):384-93. PubMed ID: 23659687
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
Meng G; Liu Y; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
Eur J Med Chem; 2014 Jul; 82():600-11. PubMed ID: 24952305
[TBL] [Abstract][Full Text] [Related]
25. Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties.
Kang D; Zhang H; Wang Z; Zhao T; Ginex T; Luque FJ; Yang Y; Wu G; Feng D; Wei F; Zhang J; De Clercq E; Pannecouque C; Chen CH; Lee KH; Murugan NA; Steitz TA; Zhan P; Liu X
J Med Chem; 2019 Feb; 62(3):1484-1501. PubMed ID: 30624934
[TBL] [Abstract][Full Text] [Related]
26. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives.
Buemi MR; Gitto R; Ielo L; Pannecouque C; De Luca L
Bioorg Med Chem; 2020 Apr; 28(8):115431. PubMed ID: 32197813
[TBL] [Abstract][Full Text] [Related]
28. Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.
De Clercq E
Farmaco; 1999; 54(1-2):26-45. PubMed ID: 10321027
[TBL] [Abstract][Full Text] [Related]
29. Structural optimization of N
Monforte AM; De Luca L; Buemi MR; Agharbaoui FE; Pannecouque C; Ferro S
Bioorg Med Chem; 2018 Feb; 26(3):661-674. PubMed ID: 29291935
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase.
Penta A; Ganguly S; Murugesan S
Org Med Chem Lett; 2013 Aug; 3(1):8. PubMed ID: 23968361
[TBL] [Abstract][Full Text] [Related]
31. The discovery of novel diarylpyri(mi)dine derivatives with high level activity against a wide variety of HIV-1 strains as well as against HIV-2.
Lu X; Yang J; Kang D; Gao P; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Bioorg Med Chem; 2018 May; 26(8):2051-2060. PubMed ID: 29559197
[TBL] [Abstract][Full Text] [Related]
32. Discovery of Thiophene[3,2-
Kang D; Ding X; Wu G; Huo Z; Zhou Z; Zhao T; Feng D; Wang Z; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
ACS Med Chem Lett; 2017 Nov; 8(11):1188-1193. PubMed ID: 29152052
[TBL] [Abstract][Full Text] [Related]
33. Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
Medina-Franco JL; Rodríguez-Morales S; Juárez-Gordiano C; Hernández-Campos A; Jiménez-Barbero J; Castillo R
Bioorg Med Chem; 2004 Dec; 12(23):6085-95. PubMed ID: 15519154
[TBL] [Abstract][Full Text] [Related]
34. Exploiting the tolerant region I of the non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket. Part 2: Discovery of diarylpyrimidine derivatives as potent HIV-1 NNRTIs with high Fsp
Jiang X; Huang B; Olotu FA; Li J; Kang D; Wang Z; De Clercq E; Soliman MES; Pannecouque C; Liu X; Zhan P
Eur J Med Chem; 2021 Mar; 213():113051. PubMed ID: 33279288
[TBL] [Abstract][Full Text] [Related]
35. Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure-activity relationship of solvent-exposed regions I.
Kang D; Wang Z; Chen M; Feng D; Wu G; Zhou Z; Jing L; Zuo X; Jiang X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Chem Biol Drug Des; 2019 Apr; 93(4):430-437. PubMed ID: 30381875
[TBL] [Abstract][Full Text] [Related]
36. Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains.
Li A; Ouyang Y; Wang Z; Cao Y; Liu X; Ran L; Li C; Li L; Zhang L; Qiao K; Xu W; Huang Y; Zhang Z; Tian C; Liu Z; Jiang S; Shao Y; Du Y; Ma L; Wang X; Liu J
J Med Chem; 2013 May; 56(9):3593-608. PubMed ID: 23540737
[TBL] [Abstract][Full Text] [Related]
37. Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors.
Yan ZH; Huang XY; Wu HQ; Chen WX; He QQ; Chen FE; De Clercq E; Pannecouque C
Bioorg Med Chem; 2014 Apr; 22(8):2535-41. PubMed ID: 24680058
[TBL] [Abstract][Full Text] [Related]
38. Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors.
Liu G; Wang W; Wan Y; Ju X; Gu S
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751616
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimidine derivatives as potent human immunodeficiency virus-1 inhibitors.
Wang Z; Kang D; Chen M; Wu G; Feng D; Zhao T; Zhou Z; Huo Z; Jing L; Zuo X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Chem Biol Drug Des; 2018 Dec; 92(6):2009-2021. PubMed ID: 30079476
[TBL] [Abstract][Full Text] [Related]
40. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
Abdallah AEM; Elgemeie GH
Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
